Jaan Health, renowned for its AI-driven care platform, Phamily, has secured over $25m in funding to revolutionise care for millions of patients with chronic conditions.
The funding includes $15m in non-dilutive growth capital from Level Structured Capital, an affiliate of Level Equity, which targets fast-growing software and tech-enabled businesses.
Level Structured Capital Partner Barry Osherow said: “Jaan Health is seeing tremendous clinical demand for the Phamily platform, and sought the optimal financial partner to help them scale the next phase of their growth.
“We were impressed that they had built a strong, successful, eight-figure business without needing institutional capital.
“In a market crowded with health tech companies making claims or predictions around AI, Jaan Health stands out for their proprietary data sets, operational strength, capital efficiency, and transformational vision for patient care at scale.”
Jaan Health’s advanced patient engagement software, Phamily, empowers healthcare organisations to deliver proactive care management on a large scale.
The platform has a proven track record, serving hundreds of thousands of patients with over 250 chronic condition diagnoses.
The latest funding will bolster Phamily’s leadership in virtual care, expand its reach into new market segments, and deepen its penetration into health systems and integrated networks.
Jaan Health Founder and CEO Nabeel Kaukab said: “Managing the ongoing needs of patients with chronic diseases is by far and away the number one challenge in healthcare and cannot be solved with an occasional doctor’s visit.
“Over the past decade, we have established a novel virtual care platform and proprietary artificial intelligence, Phamily, that improves both patient outcomes and provider profitability for over 150 healthcare organisations.
“Our new funding will enable us to extend the benefits of Phamily to millions more patients across the United States.”
Jaan Health, a prominent AI-based care management company, has been serving healthcare providers across the US for nearly a decade.
The company’s in-house technology allows health systems, medical groups, and ACOs to deliver high-quality care to underserved patients using small teams and existing resources.
Its core technology platform Phamily has transformed chronic disease management.
The clinically tested AI and user-friendly software allows physicians to provide personalised, high-touch care, overcoming traditional barriers of labour constraints and care costs.
Phamily ensures fair compensation for healthcare providers, enhances patient lives, and alleviates the overall burden on taxpayers and the healthcare system.
Java Medical Group CEO Bappa Mukherji said: “Phamily makes great care management accessible to thousands of our patients who need it.
“Like many health systems, our hospitals are under crushing pressure from decreased reimbursement and healthcare labour economics.
“Phamily not only lets us provide better care but enables us to do so with massive labour efficiency and fair compensation.
“We see Phamily as a key component of our patient care strategy, and we congratulate the Jaan Health team on securing the funding that will cement their long-term success.”
